.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKinsey
AstraZeneca
QuintilesIMS
Moodys
Boehringer Ingelheim
Fish and Richardson
Novartis
Argus Health
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,446,090

« Back to Dashboard

Which drugs does patent 7,446,090 protect, and when does it expire?


Patent 7,446,090 protects FOLLISTIM AQ and GONAL-F RFF REDI-JECT and is included in two NDAs.

This patent has twenty-eight patent family members in twenty-four countries.

Summary for Patent: 7,446,090

Title:FSH formulation
Abstract:This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.
Inventor(s): Hoffmann; James Arthur (Greenwood, IN), Lu; Jirong (Indianapolis, IN)
Assignee: Ares Trading S.A. (Aubonne, CH)
Application Number:11/482,569
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Process; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-003Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► SubscribeY
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-001Mar 23, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-002Mar 23, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Organon Usa IncFOLLISTIM AQfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021211-004Feb 11, 2005RXYesYes► Subscribe► Subscribe► SubscribeY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-001May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-002May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-003May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,446,090

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,563,763FSH and FSH variant formulations, products and methods► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,446,090

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia0974359► Subscribe
Portugal974359► Subscribe
Poland346127► Subscribe
Peru09392000► Subscribe
New Zealand508874► Subscribe
Norway20010326► Subscribe
Malaysia135913► Subscribe
Japan4719357► Subscribe
Japan2002521342► Subscribe
Israel140984► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Dow
AstraZeneca
US Department of Justice
Cantor Fitzgerald
Farmers Insurance
Chubb
Cerilliant
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot